Does the circulating biomarker sST2 predict atrial fibrillation development and recurrence after successful catheter ablation?
The biomarker sST2 may serve as a useful clinical tool for predicting both the initial development of atrial fibrillation and its recurrence following catheter ablation.
The circulating biomarker sST2 has an essential role in AF development. Moreover, sT2 is a significant predictor for recurrent AF after a successful catheter ablation procedure.
Waranugraha et al. (Thu,) studied this question.